Lenox Wealth Advisors, LLC - Santen Pharmaceutical Co Ltd ownership

Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 6 filers reported holding Santen Pharmaceutical Co Ltd in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lenox Wealth Advisors, LLC ownership history of Santen Pharmaceutical Co Ltd
ValueSharesWeighting
Q1 2019$1,000
-83.3%
94
-71.6%
0.00%
-100.0%
Q2 2018$6,0003310.00%
Other shareholders
Santen Pharmaceutical Co Ltd shareholders Q2 2019
NameSharesValueWeighting ↓
PARAMETRIC PORTFOLIO ASSOCIATES LLC 1,577,090$25,659,0000.02%
MEEDER ASSET MANAGEMENT INC 199$3,0000.00%
Private Capital Group, LLC 159$3,0000.00%
IFP Advisors, Inc 0$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 625$10,0000.00%
View complete list of Santen Pharmaceutical Co Ltd shareholders